Melqart 13F holdings, Q4 2017
Holdings as of December 31, 2017 · filings on SEC EDGAR · latest filing →
Melqart disclosed 14 US equity positions worth $582.2m in its Q4 2017 13F filing. The largest position was TIME WARNER INC at 21.4% of the reported book, followed by NXPI and MONSANTO CO NEW.
What did Melqart own in Q4 2017? Top 14 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | TIME WARNER INC | 21.4% | $124.5m | 1,367,000 | – | ||
| 2 | NXPI NXP SEMICONDUCTORS N V | Technology | 16.0% | $93.3m | 797,000 | – | |
| 3 | MONSANTO CO NEW | 13.8% | $80.1m | 689,000 | – | ||
| 4 | QIW QIWI PLC | 9.3% | $54.2m | 3,129,305 | – | ||
| 5 | QCOM QUALCOMM INC | Technology | 7.7% | $44.8m | 700,000 | – | |
| 6 | COTY COTY INC | Consumer Defensive | 6.5% | $37.9m | 1,903,101 | – | |
| 7 | ATLANTICA YIELD PLC | 6.1% | $35.7m | 1,681,543 | – | ||
| 8 | EQT EQT CORP | Energy | 4.5% | $26.5m | 465,000 | – | |
| 9 | WIX WIX COM LTD | Technology | 4.4% | $25.9m | 450,000 | – | |
| 10 | DBD DIEBOLD NXDF INC | Technology | 3.1% | $18.1m | 1,110,070 | – | |
| 11 | BEMIS INC | 3.0% | $17.2m | 360,052 | – | ||
| 12 | INTERCEPT PHARMACEUTICALS IN | 2.3% | $13.1m | 225,000 | – | ||
| 13 | GGP INC | 1.6% | $9.4m | 403,700 | – | ||
| 14 | FREDS INC | 0.2% | $1.4m | 337,889 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.